Compass Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Compass Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Compass Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Compass Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $236k | 236k | 1.00 |
| 2024-03-31 | $243k | 123k | 1.98 |
| 2023-12-31 | $322k | 207k | 1.56 |
| 2023-09-30 | $434k | 220k | 1.97 |
| 2023-06-30 | $342k | 108k | 3.18 |
| 2023-03-31 | $649k | 199k | 3.27 |